Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human BMI1 Antibodies:
anti-Mouse (Murine) BMI1 Antibodies:
anti-Rat (Rattus) BMI1 Antibodies:
Go to our pre-filtered search.
Human Monoclonal BMI1 Primary Antibody for BI, IHC (f) - ABIN2688857
Dimri, Martinez, Jacobs, Keblusek, Itahana, Van Lohuizen, Campisi, Wazer, Band: The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. in Cancer research 2002
Show all 6 Pubmed References
Human Monoclonal BMI1 Primary Antibody for ChIP - ABIN2668619
Lafkas, Rodilla, Huyghe, Mourao, Kiaris, Fre: Notch3 marks clonogenic mammary luminal progenitor cells in vivo. in The Journal of cell biology 2013
Show all 2 Pubmed References
Human Monoclonal BMI1 Primary Antibody for ICC, FACS - ABIN968985
Edwards, Witherspoon, Wang, Afrasiabi, Pham, Birnbaumer, Lipkin: Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. in Cancer research 2009
Show all 2 Pubmed References
Human Polyclonal BMI1 Primary Antibody for ICC, IF - ABIN152245
Kang, Qi, Zuo, Wang, Zou, Schwartz, Cheng, Yeh: SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. in Molecular cell 2010
Human Polyclonal BMI1 Primary Antibody for IHC (fro), WB - ABIN2477677
Mandal, Boitano, Maxwell, Lou, Alexander: Ninety-eight penetrating vascular injuries: a review of a two and one-half year experience. in The Journal of trauma 1976
Show all 3 Pubmed References
Human Monoclonal BMI1 Primary Antibody for CyTOF, FACS - ABIN4900505
Shen, Chen, Ding, Qi, Cen, Wang, Yao, Chen: BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression. in Journal of cellular and molecular medicine 2014
Human Polyclonal BMI1 Primary Antibody for ICC, IF - ABIN257760
Ismail, Andrin, McDonald, Hendzel: BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. in The Journal of cell biology 2010
Human Monoclonal BMI1 Primary Antibody for WB - ABIN2477676
Sánchez, Sánchez, Demmers, Rodriguez, Strouboulis, Vidal: Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor. in Molecular & cellular proteomics : MCP 2007
Human Monoclonal BMI1 Primary Antibody for ICC, IF - ABIN2668620
Bracken, Kleine-Kohlbrecher, Dietrich, Pasini, Gargiulo, Beekman, Theilgaard-Mönch, Minucci, Porse, Marine, Hansen, Helin: The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. in Genes & development 2007
Human Monoclonal BMI1 Primary Antibody for ELISA, WB - ABIN560071
Andrews, Banting, Damjanov, Arnaud, Avner: Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. in Hybridoma 1985
Show all 2 Pubmed References
these data suggest that Bmi-1 could serve as a novel prognostic biomarker in pediatric primary acute lymphoblastic leukemia (ALL)and may be partially regulated by Sall4a (show SALL4 Antibodies). Our study also showed that Bmi-1 could serve as a new therapeutic target for the treatment of pediatric ALL.
The findings indicate that BMI1-mediated IDAX (show CXXC4 Antibodies) epigenetic suppression is crucial for enhancement of colon carcinogenesis.
BMI1 and UBR5 repress the polymerase II (Pol II)-mediated transcription at damaged sites
The development of BMI-1-targeting therapy.
High BMI1 expression is associated with gastric cancer.
Study demonstrated that Bmi1 could decrease the sensitivity of pancreatic cancer cells to gemcitabine through increasing oxidative stress and inhibiting NF-kappaB (show NFKB1 Antibodies) signaling.
findings confirmed the tumorigenic activity of HK2 (show HK2 Antibodies) in glioma, and the involvement of the miR218/Bmi1 pathway in the regulation of its expression
Data suggest that BMI1 binds to the miR (show MLXIP Antibodies)-200c/141 promoter and regulates it through transcription factor binding motifs to repress expression of miR (show MLXIP Antibodies)-200c/141 cluster.
Given that glioblastomas contain both proneural and mesenchymal GSCs, combined EZH2 (show EZH2 Antibodies) and BMI1 targeting proved more effective than either agent alone both in culture and in vivo, suggesting that strategies that simultaneously target multiple epigenetic regulators within glioblastomas may be effective in overcoming therapy resistance caused by intratumoral heterogeneity
Bmi1 expression is related to a refractory clinical course of IBD and upregulated in refractory IBD and CAC (show CA2 Antibodies).
Bmi1 plays an important role in regulating the proliferation of cochlear supporting cells.
Results from this study indicate that estrogen deficiency downregulates BMI-1 and subsequently increases ROS (show ROS1 Antibodies), T cell activation, and RANKL (show TNFSF11 Antibodies) production in T cells, thus enhancing osteoclastogenesis and accelerating bone loss.
ompounding a previously described Bmi1-transgene and Pten (show PTEN Antibodies)-deficiency prostate cancer mouse model with the Ezh2 (show EZH2 Antibodies) transgene did not enhance tumour progression or drive metastasis formation. In conclusion, we here report the generation of a wildtype Ezh2 (show EZH2 Antibodies) overexpression mouse model that allows for intravital surveillance of tissues with activated transgene
BMI1 and MEL18 (show PCGF2 Antibodies) contribute to the development of colitis-associated cancer in mice by promoting proliferation and reducing apoptosis via suppressing expression of Reg3b (show REG3B Antibodies). REG3B (show REG3B Antibodies) negatively regulates cytokine-induced activation of STAT3 (show STAT3 Antibodies) in colon epithelial cells.
Data show that C/EBPalpha (show CEBPA Antibodies) is a tumor suppressor in lung cancer and that BMI1 is required for the oncogenic process downstream of C/EBPalpha (show CEBPA Antibodies) loss.
KLF4 (show KLF4 Antibodies) modulates development of BMI1-expressing intestinal stem cell-derived lineage following gamma-radiation-induced gut (show GUSB Antibodies) injury in mice.
The retinal phenotype of Bmi1(-/-) mice was characterized by loss of heterochromatin, activation of tandem repeats, oxidative stress and Rip3 (show MPRIP Antibodies)-associated necroptosis.
Loss of BMI1 enhanced ribonuclease activity of polynucleotide phosphorylase and reduced mtRNA stability
Inducible fate mapping demonstrates that BMI1 is expressed in vivo by multipotent Olfactory epithelium progenitors. expression of BMI1 and other Polycomb (show CBX2 Antibodies) proteins not previously identified in olfactory basal cells are essential for self-renewal.
We conclude that silencing of Bmi1 by miR (show MLXIP Antibodies)-27b relieves repression of the presynaptic transcriptome and supports neurotransmission in cortical networks.
Bmi1 acts immediately downstream of CCAAT enhancer binding protein-alpha (show CEBPA Antibodies) to regulate the survival and self-renewal of hematopoietic stem cells and contribute to the erythropoietic dysplasia.
Pig Bmi1 cDNA is 3,193 bp in length and consists of a 981 bp open reading frame, a 256 bp 5 (show HSPD1 Antibodies)' untranslated region (UTR (show UTS2R Antibodies)), and a 1,956 bp 3 (show BST1 Antibodies)' UTR (show UTS2R Antibodies). The transcript contains no signal peptides and there are no transmembrane regions in the pig Bmi1 coded protein.
This locus represents naturally occurring read-through transcription between the neighboring COMM domain-containing protein 3 and polycomb complex protein BMI-1 genes on chromosome 10. The read-through transcript produces a fusion protein that shares sequence identity with each individual gene product.
B lymphoma Mo-MLV insertion region 1 homolog
, murine leukemia viral (bmi-1) oncogene homolog
, polycomb complex protein BMI-1
, polycomb group RING finger protein 4
, polycomb group protein Bmi1
, ring finger protein 51
, BMI1 polycomb ring finger oncogene
, B lymphoma Mo-MLV insertion region 1
, polycomb group ring finger 4
, polycomb complex protein BMI-1-A
, polycomb group RING finger protein 4-A
, B lymphoma Mo-MLV insertion region
, COMMD3-BMI1 read-through protein
, Polycomb group RING finger protein 4
, RING finger protein 51
, Polycomb group RING finger protein 4-B
, polycomb complex protein BMI-1-B
, polycomb group RING finger protein 4-B
, oncoprotein BMI-1